This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

6 Stocks Hit 52-Week Highs: PFE, LMT, VAL, BIIB, MSG, BYI

Stocks in this article: PFE LMT VAL BIIB MSG BYI

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Biogen Idec

"At the CONFIRM ph.III data presentation, the lead investigator specifically noted that while there have been some malignancies observed in the 1,700 patients followed in the long-term ph.III extension phase, there does not appear to be any increase in the risk of cancer vs. what would be expected in this patient population," Wells Fargo analysts wrote in a report Wednesday. "We believe this should substantially reduce any lingering concerns about the theoretical risk of malignancy with BG-12, and removes one of the overhangs on the program as BIIB moves through the FDA and EMA review processes."

Shares of Biogen Idec hit a 52-week high of $130.81 on Wednesday. The stock's 52-week low of $83.83 was set on Aug. 9.

Biogen Idec has a forward P/E of 18.45; the average for biotechnology companies is 29.93. For comparison, Amgen (AMGN) has a lower forward P/E of 10.24.

Twenty-one of the 30 analysts who cover Biogen Idec rated it buy; nine analysts gave the stock a hold rating.

TheStreet Ratings gives Biogen Idec an A grade with a buy rating and $165.31 price target. The stock has risen 17.72% year to date.

Madison Square Garden

"We remain constructive but Neutral on MSG shares, as positive catalyst potential over the NT appears limited to the Knicks and Rangers' ability to advance to second round playoffs followed by a fairly quiet summertime closure of The Garden, thus limiting 2012E upside," Bank of America Merrill Lynch analysts wrote in an April 2 report.

Shares of Madison Square Garden hit a 52-week high Wednesday of $35.49. The stock's 52-week low of $21.12 was set on Oct. 4.

Madison Square Garden's forward P/E is 26.56; the average for recreation services companies is 15.59. For comparison, International Speedway (ISCA) has a lower forward P/E of 14.28.

Analysts were split on Madison Square Garden with five giving it a buy rating, another five rating it hold and one analyst giving Madison Square Garden a sell rating.

TheStreet Ratings gives Madison Square Garden a C grade and hold rating. The stock has risen 24.04% year to date.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

3 of 4

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs